search
close_mark

Mark Richards

Mark Richards

26 Jun, 2025

Mark has 15 years of sales experience in life sciences, including 8 years in regulatory solutions.

Asya Agres
Read Now

Other Related Articles

Why Regulatory Strategy Is a Capital Allocation Decision
Blog Pharmaceutical

Why Regulatory Strategy Is a Capital Allocation Decision

27 Aug, 2026

The Hidden Cost of Regulatory Uncertainty and Missed Opportunity in Emerging Biotech
Blog Pharmaceutical

The Hidden Cost of Regulatory Uncertainty and Missed Opportunity in Emerging Biotech

26 Aug, 2026

Beyond Implementation: Why Many RIM Programs Fail to Deliver Business Value
Blog Pharmaceutical

Beyond Implementation: Why Many RIM Programs Fail to Deliver Business Value

25 Aug, 2026

The Most Expensive Mistakes in Biotech Are Often Regulatory, Not Scientific
Blog Pharmaceutical

The Most Expensive Mistakes in Biotech Are Often Regulatory, Not Scientific

20 Aug, 2026

Optimizing Systematic Literature Reviews for CERs: Common Deficiencies and How to Avoid Them
Blog Medical Devices

Optimizing Systematic Literature Reviews for CERs: Common Deficiencies and How to Avoid Them

20 Aug, 2026

M4Q(R2) Transition Readiness: Migrating CMC Content for the Structured Submissions of Tomorrow
Blog Pharmaceutical

M4Q(R2) Transition Readiness: Migrating CMC Content for the Structured Submissions of Tomorrow

19 Aug, 2026

Notified Body Opinion (NBOp) for Combination Products: Navigating Article 117 of the EU MDR
Blog Medical Devices

Notified Body Opinion (NBOp) for Combination Products: Navigating Article 117 of the EU MDR

19 Aug, 2026

Received a Notified Body Deficiency Letter for Your CER? Here’s What to Do Next
Blog Medical Devices

Received a Notified Body Deficiency Letter for Your CER? Here’s What to Do Next

13 Aug, 2026

View All